ETS-related transcription factor Elf-2 Antibody [PCRP-ELF2-3A9]

In Stock
Catalog Number Formulation Size Price
1998-MSM2-P0
Purified Ab with BSA and Azide at 200ug/ml
20ug
$259.00
1998-MSM2-P1
Purified Ab with BSA and Azide at 200ug/ml
100ug
$559.00
1998-MSM2-P1ABX
Purified Ab WITHOUT BSA or Azide at 1.0mg/ml
100ug
$559.00
Flat Rate Domestic: $95 | Orders outside the US - Contact Us for Order Information | Ships next business day

Applications & Dilutions

Applications Tested Dillution Protocol
Flow Cytometry (Flow)
1-2ug/million cells
Immunofluorescence (IF)
1-3ug/ml

Summary

Isoform 1 transcriptionally activates the LYN and BLK promoters and acts synergistically with RUNX1 to transactivate the BLK promoter., Isoform 2 may function in repression of RUNX1-mediated transactivation.

Product Properties & Targets

Antibody Type
Host
Mouse
Species Reactivity
Isotype / Light Chain
IgG /
Cellular Localization
Nucleus
Gene Name
Positive Control
Expressed in all fetal and adult tissues examined
Immunogen
Recombinant human ELF2 protein
Alternate Names
ETS-related transcription factor Elf-2, EU32|NERF|NERF-1A|NERF-1B|NERF-1a|b|NERF-2

Database Links

Entrez Gene ID
SwissProt

Additional Information

Clone
PCRP-ELF2-3A9
Chromosome Location
4q31.1
Mol. Weight of Antigen
63.97kDa
Purification
Protein A

Functions

  • Isoform 1 transcriptionally activates the LYN and BLK promoters and acts synergistically with RUNX1 to transactivate the BLK promoter., Isoform 2 may function in repression of RUNX1-mediated transactivation.

Storage & Stability

Antibody with azide - store at 2 to 8 °C. Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

Limitations

This antibody is available for research use only and is not approved for use in diagnosis.

Supplied as

200ug/ml of Ab purified from Bioreactor Concentrate by Protein A. Prepared in 10mM PBS with 0.05% BSA & 0.05% azide. Also available WITHOUT BSA & azide at 1.0mg/ml.

Warranty

There are no warranties, expressed or implied, which extend beyond this description. Company is not liable for any personal injury or economic loss resulting from this product.
PARTNERSHIP OPPORTUNITIES

NeoBiotechnologies holds Exclusive rights to 10,000 recombinant and hybridoma antibody products, available for Licensing or Collaboration.

LETS TALK